The Effect of Periodontal Health on Smile (EPHS)

February 2, 2025 updated by: Tuğba ŞAHİN, Abant Izzet Baysal University

Investigation of the Effect of Periodontal Health on Smile Parameters: a Cross-Sectional

Anamnesis was taken from 108 patients aged 18-33 who applied to the clinic and met the inclusion criteria. Photographs of the patients' smiles were taken without any measurement. Plaque , gingival index , bleeding on probing, pocket depth measurements, clinical attachment, and gingival recession levels were measured, respectively. Patients were divided into two groups: peri-implant health and gingivitis. Gingival thickness and keratinized gingival width were also measured. In addition, the smile aesthetic index, style, type, and stage were also determined using the smile classification system. Gingival visibility was measured in mm from the photographs taken.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

108

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bolu, Turkey, 14030
        • Bolu Abant İzzet Baysal Üniversity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

108 systemically healthy individuals between 13 and 33 years of age

Description

Inclusion Criteria:

  • No systemic disease

Exclusion Criteria:

  • Active smoking,
  • Ongoing or past orthodontic treatment,
  • Pregnancy,
  • Nursing,
  • Individuals who have drug-induced gingival hyperplasia, hereditary gingival fibromatosis, permanent or removable prostheses in the upper front area, or missing teeth in the front region

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Periodontal health
It includes gingival healthy individuals without any periodontal disease.
The presence or absence of periodontal disease in the gingiva was determined.
Gingivitis
It includes individuals with gingivitis.
The presence or absence of periodontal disease in the gingiva was determined.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Keratinized gingival thickness
Time Frame: Baseline
Keratinized gingival thickness refers to the vertical measurement of the gingival tissue that extends from the free gingival margin to the mucogingival junction, characterized by a keratinized epithelial layer which provides enhanced protection and stability to the underlying periodontal structures.
Baseline
Keratinized gingival width
Time Frame: Baseline
Keratinized gingival width refers to the horizontal dimension of the gingival tissue that is keratinized, measured from the free gingival margin to the mucogingival junction.
Baseline
Gingival display
Time Frame: Baseline
The gingival displays were measured by measuring the distances from the zenith points to the vermilion border
Baseline
Smile esthetic index
Time Frame: Baseline
. The aforementioned factors were assigned a number (0 or 1) depending on their presence or absence, and the total of the assigned numbers indicates the subject's SEI (which ranges from 0 for very poor to 10 for very good)
Baseline
Smile clasificatain system
Time Frame: Baseline
Smile style (Commissura smile, sharp smile, and complex smile), stage (Stage I, Stage II, Stage III, and Stage IV), and type (Type 1, Type 2, Type 3, and Type 4) were analyzed with the smile classification system
Baseline
Gingival phenotype
Time Frame: Baseline
The visible end of the periodontal probe in the sulcus represents a thin gingival phenotype, while the invisible end corresponds to a thick gingival phenotype
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bleeding on probing
Time Frame: Baseline
Bleeding, leading sign of inflammation inside the connective tissue, is a critical factor for pocket depth measurements, and with other variable factors prevents making reproducible measurements.
Baseline
Plaque index
Time Frame: Baseline
The plaque index assesses the amount of dental plaque visible on the vestibular and lingual surfaces of all teeth
Baseline
Clinical attachment level
Time Frame: Baseline
CAL is calculated by subtracting the gingival margin level from the probing depth.
Baseline
Gingival index
Time Frame: Baseline
This measurement is based on the presence or absence of bleeding on gentle probing
Baseline
Gingival recession depth
Time Frame: Baseline
Gingival recession is the apical migration of the gingival margin away from the cemento-enamel junction (CEJ), resulting in the exposure of the root surface of a tooth.
Baseline
Periodontal pocket depth
Time Frame: Baseline
A pathologically deepened gingival sulcus around a tooth at the gingival margin.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2023

Primary Completion (Actual)

May 15, 2023

Study Completion (Actual)

June 25, 2023

Study Registration Dates

First Submitted

August 11, 2024

First Submitted That Met QC Criteria

August 11, 2024

First Posted (Actual)

August 15, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 2, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • AIBU-DH-TS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gingival Diseases

Clinical Trials on Periodontal health and gingivitis

Subscribe